Recruitment

Recruitment Status
Completed
Estimated Enrollment
1500

Summary

Conditions
Human Papillomavirus Infection
Type
Interventional
Phase
Phase 3
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Prevention

Participation Requirements

Age
Between 9 years and 26 years
Gender
Both males and females

Tracking Information

NCT #
NCT01984697
Collaborators
Not Provided
Investigators
Study Director: Medical Director Merck Sharp & Dohme Corp.